136 related articles for article (PubMed ID: 16609701)
1. ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2.
Hong L; Qiao T; Han Y; Han S; Zhang X; Lin T; Gao J; Zhao P; Chen Z; Fan D
Biochem Cell Biol; 2006 Apr; 84(2):199-206. PubMed ID: 16609701
[TBL] [Abstract][Full Text] [Related]
2. Reversal of multidrug resistance of gastric cancer cells by down-regulation of ZNRD1 with ZNRD1 siRNA.
Hong L; Ning X; Shi Y; Shen H; Zhang Y; Lan M; Liang S; Wang J; Fan D
Br J Biomed Sci; 2004; 61(4):206-10. PubMed ID: 15649014
[TBL] [Abstract][Full Text] [Related]
3. Effect of ZNRD1 gene antisense RNA on drug resistant gastric cancer cells.
Zhang YM; Zhao YQ; Pan YL; Shi YQ; Jin XH; Yi H; Fan DM
World J Gastroenterol; 2003 May; 9(5):894-8. PubMed ID: 12717826
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of ZNRD1 promotes multidrug-resistant phenotype of gastric cancer cells through upregulation of P-glycoprotein.
Shi Y; Zhang Y; Zhao Y; Hong L; Liu N; Jin X; Pan Y; Fan D
Cancer Biol Ther; 2004 Apr; 3(4):377-81. PubMed ID: 14726695
[TBL] [Abstract][Full Text] [Related]
5. Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2.
Hong L; Piao Y; Han Y; Wang J; Zhang X; Du Y; Cao S; Qiao T; Chen Z; Fan D
Mol Cancer Ther; 2005 Dec; 4(12):1936-42. PubMed ID: 16373708
[TBL] [Abstract][Full Text] [Related]
6. Regulation of multidrug resistance by ribosomal protein l6 in gastric cancer cells.
Du J; Shi Y; Pan Y; Jin X; Liu C; Liu N; Han Q; Lu Y; Qiao T; Fan D
Cancer Biol Ther; 2005 Feb; 4(2):242-7. PubMed ID: 15846068
[TBL] [Abstract][Full Text] [Related]
7. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
[TBL] [Abstract][Full Text] [Related]
8. [Expression and function of zinc ribbon gene ZNRD1 in drug-resistant gastric cancer cells].
Zhang YM; Zhao YQ; Yan QJ; Pan YL; Yi H; Fan DM
Zhonghua Zhong Liu Za Zhi; 2003 Mar; 25(2):125-9. PubMed ID: 12795835
[TBL] [Abstract][Full Text] [Related]
9. [Reversal of multidrug resistance of gastric cancer cells by down-regulation of CIAPIN1 with CIAPIN1 siRNA].
Li X; Fan R; Zou X; Hong L; Gao L; Jin H; Du R; He L; Xia L; Fan D
Mol Biol (Mosk); 2008; 42(1):102-9. PubMed ID: 18389626
[TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance of adriamycin-resistant gastric adenocarcinoma cells through the up-regulation of DARPP-32.
Hong L; Zhao Y; Wang J; Han Y; Guo W; Jin H; Zhai H; Bai F; Zhang X; Qiao T; Chen Z; Fan D
Dig Dis Sci; 2008 Jan; 53(1):101-7. PubMed ID: 17492506
[TBL] [Abstract][Full Text] [Related]
11. miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.
Zhu W; Zhu D; Lu S; Wang T; Wang J; Jiang B; Shu Y; Liu P
Med Oncol; 2012 Mar; 29(1):384-91. PubMed ID: 21258880
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of human erythroleukemia K562 cells resistant to methotrexate by inhibiting IMPDH.
Peñuelas S; Noé V; Morales R; Ciudad CJ
Med Sci Monit; 2005 Jan; 11(1):BR6-12. PubMed ID: 15614187
[TBL] [Abstract][Full Text] [Related]
13. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway.
Lian W; Zhang L; Yang L; Chen W
Apoptosis; 2017 Jul; 22(7):933-941. PubMed ID: 28439677
[TBL] [Abstract][Full Text] [Related]
14. Identification of proteins responsible for the development of adriamycin resistance in human gastric cancer cells using comparative proteomics analysis.
Yang YX; Hu HD; Zhang DZ; Ren H
J Biochem Mol Biol; 2007 Nov; 40(6):853-60. PubMed ID: 18047778
[TBL] [Abstract][Full Text] [Related]
15. [Reversion of multidrug resistance in HL-60/VCR cells by down-regulation of bcl-2 with bcl-2 siRNA].
Piao Y; Chen XQ; Liu LM; Hong L; Liu JH; Zhou F; Liu YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1010-3. PubMed ID: 16403269
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of ZNRD1 enhances cisplatin resistance in human esophageal cancer cells by regulation of ERCC1 and Bcl-2.
Guo W; Zhao YP; Jiang YG; Wang RW; Hong L; Fan DM
Tumour Biol; 2008; 29(3):188-94. PubMed ID: 18645262
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
19. Gastrin induces multidrug resistance via the degradation of p27Kip1 in the gastric carcinoma cell line SGC7901.
Zhuang K; Zhang L; Zhang X; Tang H; Zhang J; Yan Y; Han K; Guo H
Int J Oncol; 2017 Jun; 50(6):2091-2100. PubMed ID: 28498440
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
